Indonesia overhauls patent enforcement

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Indonesia overhauls patent enforcement

Lawmakers in Indonesia have recognized the importance of patents to economic activity by providing for the speedy resolution of disputes under the new Patent Law. Cita Priapantja explains the most important features of the new legislation

The Patent (Amendment) Law Number 14 of 2001 became effective from August 1 this year. However, the implementing regulations have not yet been issued by the government. The major changes under the new Patent Law involve perfection, addition and elimination.

An invention is deemed to be novel if on the filing date the invention is not the same as the prior art. What is meant by prior art is technology which has been published in Indonesia or outside Indonesia, in a written form, verbal description, or by a demonstration of its use, or in any other way that would enable a specialist to implement said invention before the filing date or priority date. The aforesaid prior art includes documents of patent applications filed in Indonesia which are published on or after the filing date on which their substantive examinations are being processed, but said filing date is earlier than the filing date or the priority date of application.

Simple patents

Any invention being a product or equipment which is novel and having practical value because of its shape, configuration, construction or components, may be granted legal protection in the form of a simple patent. A publication period is also valid for a simple patent, and it will be carried out three months at the latest from the filing date. The legal protection for a simple patent now begins from the filing date to provide opportunities for the simple patent holder to file a claim for indemnification against infringements which might have taken place after the filing date. Claims for remedy may be filed after the granting of a simple patent. The substantive examination period is 24 months from the filing date.

A patent shall not be granted to the following inventions:

  • A process or product of which the announcement and use or implementation contravenes the prevailing regulations, religious code, public order, or morality.

  • Methods of examination, treatment, medication, and/or surgery applied to people and/or animals, if such examination, treatment, medication and/or surgery shall involve the use of medical equipment. This provision is applied only for the method of invention. Others, such as medical equipment including the means, components or medicine shall be exempt from this provision.

  • A theory and method in the field of science and mathematics.

  • All living beings, except microorganisms.

  • Essential biological processes to reproduce plants or animals, except non-biological processes or micro-biological processes.

Quick end to disputes

As patenting is very closely associated with economic and trade activities, all civil cases involving patents must be quickly adjudicated, and therefore, civil cases should be adjudicated at the Commercial Court and not the District Court.

The Directorate General of Intellectual Property has been authorized to issue compulsory licences. This is intended to simplify the procedures and improve services to the public.

A temporary injunction is provided as the first effort to prevent further damage to the party whose right has been infringed. Therefore, the Commercial Court, at the request of the applicant, is authorized to produce immediate and effective judgment, so as to prevent further infringement, the continued supply of goods suspected to involve patent infringements into the markets, as well as the importation thereof.

However, as an alternative, disputes can be settled through an arbitration body or by way of other methods of alternative dispute resolution such as negotiation, mediation, conciliation, or other means selected by the relevant parties concerned, in accordance with the prevailing laws.

Parallel importation legal

The scope of the acts which would constitute an infringement under the new Patent Law has also been restricted. The new Patent Law provides that parallel importation of patented products will not amount to an infringement. This is presumably aimed at enhancing competition by enabling consumers to obtain genuine patented products at more competitive prices. Similarly, the use of a pharmaceutical patent in Indonesia within a period of two years before the expiry of the patent protection will also not amount to an infringement if such use is for the purpose of obtaining approval and thereupon conduct marketing upon the expiry of the patent protection. This exemption is to ensure the supply of pharmaceutical products by other parties after the patent protection has expired. In this way, prices can be maintained at reasonable levels.

Patent applications filed before the enactment of this new Patent Law, will be processed according to Law Number 6 of 1989 concerning patent as amended by Law Number 13 of 1997 concerning the Amendment on Law Number 6 of 1989 concerning patent.

© Cita Citrawinda Priapantja 2001. The author is an IPR consultant with Biro Oktroi Roosseno in Jakarta

more from across site and SHARED ros bottom lb

More from across our site

Six hires across the IP spectrum reflect Orrick’s efforts to better serve tech clients across the IP lifecycle
David Stone, partner at White & Case, argues that the government’s planned reforms will modernise and futureproof UK design law, but leave two of the thorniest problems unresolved
Max Scott will join the firm’s IP transactions group in California, becoming the latest Weil IP partner to secure their future
Yonatan Drori, attorney at Drori-Stav IP in Israel, explains why foreign counsel must treat Israel’s patent disclosure requirements as an ongoing obligation, rather than a one-off formality
From Japan to Southeast Asia, domestic and regional firms picked up some of the biggest prizes, while key foreign players maintained momentum
Earlier this month, Managing IP had exclusively reported that the French arm of Taylor Wessing was minded to pull out of the deal
Our latest podcast examines how Weil’s IP practice evolved, where its practitioners could (and will) go next, and which firms and markets stand to benefit from the redistribution of talent
Former Latham partner Chris Henry and transactions lawyer Liza Cotter are heading to the firm as Weil’s IP practice starts to disperse
Rival IP teams return to court for a closely watched appeal over AI and copyright, but observers hoping for answers to some of the technology’s biggest legal questions may be left disappointed
Eight years after its launch, members of the Australian patent firm’s Singapore office explain its growth strategy over the past year
Gift this article